Why the study?
Does Angiotensin II Receptor Blockade improve muscle regeneration and decrease fibrosis in normal skeletal muscle after injury?
Population
Normal skeletal muscle with injury
Design
Preclinical
Authors
Loading...
Hypothesis-generating for ARBs after muscle injury; prospective trials needed before clinical adoption.
Does Angiotensin II Receptor Blockade improve muscle regeneration and decrease fibrosis in normal skeletal muscle after injury?
Angiotensin receptor blockers may offer a clinically available pharmacological strategy to enhance healing and reduce fibrosis following skeletal muscle injury.
Bedair et al. (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: